OUR EXPERIENCE, YOUR QUALITY OF LIFE

Site www.bendavar.com is available with information related to this product and its use, in addition to an online library with many articles of interest to practitioners.

| KYPROLIS

Active Subtance:
Carfilzomib

Indications:

Kyprolis injectable is indicated for the treatment of patients with Multiple Myeloma that have received at least two previous treatments, including Bortezomib and an immunomodulatory agent and have demonstrated progression of the illness during or within the 60 days following the finalization of the last therapy. 

Contraindications:
Unknown